(Q39380524)

English

Investigation of imatinib and other approved drugs as starting points for antidiabetic drug discovery with FXR modulating activity

scientific article

Statements

Investigation of imatinib and other approved drugs as starting points for antidiabetic drug discovery with FXR modulating activity (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit